AMED Translational Research Grant (TR program)
Supports AMED Translational Research programs helping move medical discoveries into practical medicine, device, and therapy development.
About
AMED Translational Research Grant (TR program) sits under the Japan Agency for Medical Research and Development, the national medical R&D agency established on April 1, 2015. AMED reported a FY2026 budget of JPY 116.9 billion and oversees drug discovery, medical devices, regenerative medicine, infectious disease research, data use, and the medical innovation ecosystem, so the TR track belongs to a…
Max award¥3.4M
Realistic median—
Success rate—
Decision time—
No upcoming rounds verified. Cadence: Annual.